Featured News

What if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.

New research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage celiac disease.  In celiac disease, gluten causes inflammation and damage to the intestines. This happens because gluten attaches to specific proteins in the body called…

A new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free  foods, the authors address several economic issues associated with celiac disease, including direct costs like healthcare services and medical management, as well as indirect costs such as reduced work…

Use the Power of Your Story to Advocate for Federal Funding and Awareness Join the Celiac Disease Foundation’s Congressional District Days from August 5 to September 6, 2024, and help us keep up our momentum on Capitol Hill! Thanks to our advocacy, we’ve secured crucial NIH and Department of Defense funding for groundbreaking celiac disease…

A new study from researchers at Penn State College of Medicine reveals significant differences in micronutrient deficiencies and healthcare utilization among minority patients with celiac disease (CeD) compared to their non-Hispanic white counterparts. Previous research has identified racial disparities in CeD, though they have largely been related to underdiagnosis in minority groups. However, more research…

The Celiac Disease Foundation is proud to share that for the second year in a row, access to funding for celiac disease research is being made available through the U.S. DOD Congressionally Directed Medical Research Programs (DOD-CDMRP)Peer Review Medical Research Program.

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

The Celiac Disease Foundation is proud to continue our partnership with the Boston Children's Hospital in presenting "Celiac Smarts," a live-streamed symposium for the health care and celiac patient communities. Recording available now.

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.

The ACeD-it Study is looking for adult volunteers with celiac disease to join a phase 1b/2 clinical trial. Your participation could make a difference.